Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Retta, S. F.
Right arrow Articles by Tarone, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Retta, S. F.
Right arrow Articles by Tarone, G.

Vol. 9, Issue 4, 715-731, April 1998

beta 1-Integrin Cytoplasmic Subdomains Involved in Dominant Negative Function

S. Francesco Retta,*dagger Dagger Fiorella Balzac,* Piercarlo Ferraris,* Alexey M. Belkin,§ Reinhard Fässler,par Martin J. Humphries, Giacomo De Leo,dagger Lorenzo Silengo,* and Guido Tarone*

 *Department of Genetics, Biology, and Medical Chemistry, University of Torino, 10126 Torino, Italy;  dagger Institute of Biology, University of Palermo, 90133 Palermo, Italy;  §Department of Biochemistry, American Red Cross, Rockville, MD 20855;  par Department of Experimental Pathology, Lund University S-22285 Lund, Sweden; and  School of Biological Sciences, University of Manchester, M13 9PT Manchester, United Kingdom

Submitted November 2, 1997; Accepted January 6, 1998
Monitoring Editor: Richard Hynes

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The beta 1-integrin cytoplasmic domain consists of a membrane proximal subdomain common to the four known isoforms ("common" region) and a distal subdomain specific for each isoform ("variable" region). To investigate in detail the role of these subdomains in integrin-dependent cellular functions, we used beta 1A and beta 1B isoforms as well as four mutants lacking the entire cytoplasmic domain (beta 1TR), the variable region (beta 1COM), or the common region (beta 1Delta COM-B and beta 1Delta COM-A). By expressing these constructs in Chinese hamster ovary and beta 1 integrin-deficient GD25 cells (Wennerberg et al., J Cell Biol 132, 227-238, 1996), we show that beta 1B, beta 1COM, beta 1Delta COM-B, and beta 1Delta COM-A molecules are unable to support efficient cell adhesion to matrix proteins. On exposure to Mn++ ions, however, beta 1B, but none of the mutants, can mediate cell adhesion, indicating specific functional properties of this isoform. Analysis of adhesive functions of transfected cells shows that beta 1B interferes in a dominant negative manner with beta 1A and beta 3/beta 5 integrins in cell spreading, focal adhesion formation, focal adhesion kinase tyrosine phosphorylation, and fibronectin matrix assembly. None of the beta 1 mutants tested shows this property, indicating that the dominant negative effect depends on the specific combination of common and B subdomains, rather than from the absence of the A subdomain in the beta 1B isoform.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Integrins are alpha /beta heterodimeric transmembrane cell surface receptors that mediate cell adhesion and migration and also the bidirectional transfer of information across the plasma membrane. These properties are essential in regulating several biological processes, including morphogenesis, immune response, cell growth, differentiation, and survival (Hynes, 1992; Ruoslahti and Reed, 1994).

The cytoplasmic domains of integrin subunits are required for these functions (Hibbs et al., 1991; Yamada and Miyamoto, 1995; Dedhar and Hannigan, 1996). In vitro, the isolated beta 1 cytoplasmic domain was shown to bind talin, alpha -actinin, and paxillin, three cytoskeletal proteins that mediate the anchorage of actin filaments to the plasma membrane (Chen et al., 1995; Otey et al., 1993; Schaller et al., 1995). Binding of the beta 1 cytoplasmic sequence to focal adhesion kinase (FAK), a tyrosine kinase specifically localized to focal adhesions, and to the serine/threonine kinase integrin-linked kinase has also been reported (Schaller et al., 1995; Hannigan et al., 1996). In vivo, the beta 1 cytoplasmic domain is sufficient for its localization to preformed focal adhesions (LaFlamme et al., 1992, Akiyama et al., 1994) and for the initiation of signaling to FAK (Lukashev et al., 1994). A model has been proposed in which the beta 1 subunit cytoplasmic domain contains a default signal for interaction with cytoskeletal molecules that is masked by the alpha  subunit cytoplasmic domain (Briesewitz et al., 1993; Ylanne et al., 1993). In response to matrix ligands or to multivalent antibody binding, the inhibitory effect of the alpha  subunit can be released, and integrins can interact with cytoskeletal and signaling molecules (Miyamoto et al., 1995a,b).

Integrins can activate different intracellular signals, including tyrosine phosphorylation of a number of cellular proteins, elevation of the intracellular calcium level, cytoplasmic alkalinization, alteration in phospholipid metabolism, and activation of MAP kinases (Clark and Brugge, 1995; Schaller et al., 1995). The most studied pathway is represented by the activation of the FAK tyrosine kinase (Guan et al., 1991; Burridge et al., 1992). Tyrosine-phosphorylated FAK can function as a docking site for both cytoskeletal proteins, such as paxillin and talin, and signaling molecules, such as Src family tyrosine kinases, Grb2, and phosphatidyl inositol-3 kinase (Schaller and Parson, 1994; Burridge and Chrzanowska-Wodnicka, 1996). These interactions are important for coordinating actin cytoskeleton organization and gene expression and, thus, for regulating cell migration, proliferation, differentiation, and survival (Schwartz et al., 1995).

In addition to outside-in signaling, integrins can also transduce signals from the inside to the outside of the cell. The inside-out signaling occurs mainly in the form of regulation of the ligand-binding affinity state (Ginsberg et al., 1992; O' Toole et al., 1994). By acting on the cytoplasmic domain, intracellular signals can modify the conformation of the integrin extracellular domain and, therefore, modify ligand binding capacity (O' Toole et al., 1994).

The amino acid sequences of the beta  cytoplasmic domain that are important for outside-in and inside-out signaling have been mapped in some detail. Three major sites in the beta 1 cytoplasmic domain, termed cyto-1, 2, and 3, are important for localization of the integrin heterodimer to focal adhesions (Reszka et al., 1992). The cyto-1 site is proximal to the lipid bilayer and partially overlaps with the putative binding sites for FAK, paxillin, and alpha -actinin (Otey et al., 1993; Schaller et al., 1995). In beta 3-integrin, a region N-terminal to cyto-1 interacts with the highly conserved sequence GFFKR of the alpha  subunits and is involved in the regulation of ligand-binding affinity (Hughes et al., 1996). The cyto-2 and cyto-3 sites correspond to two NPXY motifs and are also important for regulating the affinity state of the ectodomain (O'Toole et al., 1995).

Interestingly, four isoforms of the beta 1-integrin exist in humans, differing in their cytoplasmic sequence as well as in their functional properties (Balzac et al., 1994; Fornaro et al., 1995; Belkin et al., 1996). Based on the structural properties of the four splicing variants, the beta 1 cytoplasmic domain can be divided in two subdomains that we refer to as "common" and "variable" subdomains, respectively. The common subdomain consists of the 25 amino acid residues proximal to the membrane coded for by exon 6 (Altruda et al., 1990; Baudoin et al., 1996) and is shared by all four variants. This region is highly conserved among different beta  subunits and contains the cyto-1 site (Reszka et al., 1992) and the putative binding sites for FAK, paxillin (Schaller et al., 1995), and alpha -actinin (Otey et al., 1993). The variable subdomain extending toward the C terminus is coded for by different exons (Baudoin et al., 1996) and characterizes the four different beta 1 isoforms: beta 1A, beta 1B, beta 1C, and beta 1D. The beta 1A variable subdomain contains cyto-2 and cyto-3 sites, whereas that of beta 1B is characterized by a unique amino acid sequence lacking both sites. We have shown that these structural features have important consequences for the functional properties of beta 1A and beta 1B. In fact, whereas beta 1A is capable of triggering FAK tyrosine phosphorylation and localizing to focal adhesions, beta 1B lacks both functions (Balzac et al., 1994). Moreover, beta 1B acts as a dominant negative inhibitor, when expressed in Chinese hamster ovary (CHO) cells, by interfering with cell spreading and migration promoted by endogenous beta 1A (Balzac et al., 1993, 1994).

To investigate the structural basis of the beta 1B dominant negative effect further, we prepared different mutants lacking either the beta 1 cytoplasmic domain variable or common region. These constructs, together with beta 1B, were expressed both in GD25 cells, which express alpha Vbeta 3/5 and lack beta 1 as a consequence of gene knockout (Wennerberg et al., 1996), and in CHO cells, which express endogenous hamster beta 1A. In these cellular systems we show that beta 1B acts as dominant negative on adhesive and signaling function of both beta 1- and beta 3/5-integrins. Analysis of mutants molecules shows that this dominant negative action is attributable to the unique beta 1B cytoplasmic domain.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Antibodies and Reagents

The following antibodies were used: the rat anti-human beta 1 mAb 13 (Akiyama et al., 1989) was a gift from K. Yamada (National Institutes of Health, Bethesda, MD); the activating mouse anti-human beta 1 mAb TS2/16 (Hemler et al., 1984) was obtained from American Type Culture Collection (Rockville, MD); the mouse anti-human beta 1 mAb 12G10 was characterized previously (Mould et al., 1995); the rat anti-mouse beta 1 mAb 9EG7, with human cross-reactivity (Lenter et al., 1993), was a gift from D. Vestweber (ZMBE Technologiehof, Muenster, Germany); the blocking mouse anti-human beta 1 mAb AIIB2 (Werb et al., 1989) was a gift from C. Damsky (Department of Stomatology, University of California, San Francisco, CA); the inhibitory PB1 mAb against hamster alpha 5beta 1 heterodimer was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA); the blocking anti-mouse alpha V H9.2B8 mAb (Moulder et al., 1991) was purchased from PharMingen (San Diego, CA); the rat anti-mouse alpha 6 mAb GoH3 (Sonnenberg et al., 1988) was a gift from A. Sonnenberg (The Neederland Cancer Institute, Amsterdam, the Netherlands); the anti-talin mAb 8d4 was obtained from Sigma (St. Louis, MO); the anti alpha -actinin mAb 1682 was from Chemicon (Temecula, CA); rabbit polyclonal antisera to human fibronectin and to alpha V, alpha 3, and alpha 5 integrin cytoplasmic domains were produced in our laboratory (Tarone et al., 1984, Defilippi et al., 1992); the FAK 4 polyclonal antibody and the mAb FAK9.2 for FAK immunoprecipitation and Western blotting, respectively, were prepared in our laboratory as described previously (Defilippi et al., 1995); a mouse anti-paxillin mAb and the anti-phosphotyrosine mAb PY20 were purchased from Transduction Laboratories (Nottingham, UK); fluorescein-labeled phalloidin, fluorescein-labeled goat anti-mouse IgG, rhodamine-labeled goat anti-mouse IgG, and rhodamine-labeled goat anti-rabbit IgG were all from Sigma. Fibronectin was purified from human plasma by affinity chromatography on gelatin-Sepharose according to the method of Engvall and Ruoslahti (1977); mouse laminin-1 was obtained from GIBCO BRL (St. Louis, MO); the peptides GRGDSP and GRGESP were synthesized by Drs. L. Lozzi and P. Neri (University of Siena, Siena, Italy).

Integrin beta 1 Cytoplasmic Domain Mutagenesis and cDNA Vector Construction

Restriction enzymes, T4 DNA ligase, and a Klenow fragment of DNA polymerase were from New England Biolabs (Beverly, MA); Taq DNA polymerase was from Promega (Madison, WI). The SV40-based expression vector pECE (Ellis et al., 1986) containing the beta 1A and beta 1B cDNA fragments was described previously (Giancotti and Ruoslahti, 1990; Balzac et al., 1993). These plasmids were used to generate four cytoplasmic domain deletion mutants of human beta 1-integrin as follows. The HindIII cloning site of pECE was eliminated (pECE/H-), and the 417-bp HindIII cDNA fragment, containing the entire cytoplasmic domain and a part of the transmembrane domain of human beta 1A, was excised and substituted with either a HindIII synthetic oligonucleotide fragment constituting the transmembrane and the cytoplasmic domain up to isoleucine residue 762 or a HindIII PCR fragment extending to the end of the beta 1 cytoplasmic common subdomain (threonine residue 782), followed by two stop codons, to generate the plasmids pECE/H--beta 1TR and pECE/H--beta 1COM, respectively. The internal deletion of the common subdomain (from isoleucine 762 to threonine 782 in the amino acid sequence) of beta 1A and beta 1B cDNA fragments was obtained by recombinant PCR mutagenesis (Higuchi, 1990). The resulting PCR fragments were used to generate the plasmid pECE/H--beta 1Delta COM-A and pECE/H--beta 1Delta COM-B. Each mutant cDNA sequence was confirmed by dideoxy sequencing (T7 sequencing kit; Pharmacia Biotech, Upsala, Sweden).

Cells and Transfections

CHO cells expressing human beta 1A- or beta 1B-integrin isoforms or the relative deletion mutants beta 1TR, beta 1COM, beta 1Delta COM-A, and beta 1Delta COM-B were obtained by cotransfection with pSV2-neo using the calcium phosphate precipitation method as described (Balzac et al., 1993). The GD25 cell line, derived from beta 1-deficient embryonic stem cells (Wennerberg et al., 1996), was transfected with beta 1B, beta 1A, beta 1TR, and beta 1COM expression constructs, together with the plasmid pECV6-hyg (Belt et al., 1989), by electroporation. Resistant populations were selected in medium containing 300 µg/ml hygromycin beta  (Boehringer Mannheim, Mannheim, Germany).

After 10 d of selection, both CHO and GD25-positive cells were sorted for beta 1 expression by a modification of the panning method (Margolskee et al., 1993). Briefly, transfected cells were adsorbed to bacteriological dishes coated with 10 µg/ml sterile-filtered anti-human beta 1 mAb TS2/16 in PBS and allowed to attach for 5-30 min at 4°C. Dishes were then rinsed several times with PBS to remove unbound cells, and adherent cells were detached from the substrate by trypsin-EDTA treatment and transferred to tissue culture dishes. To select populations expressing high levels of all beta 1 forms used, five cycles of panning in stringent conditions (short time of cell adhesion) were performed.

Integrin Analysis by Flow Cytometry and Immunoprecipitation

The expression level of transfected beta 1 integrins and their conformational state was measured by FACS analysis. Cells were suspended in PBS [10 mM phosphate buffer (pH 7.3) and 150 mM NaCl] containing 1 mg/ml BSA. One millimolar MnCl2 was also added when indicated. The cells were then incubated for 1 h at 4°C with saturating concentrations of beta 1 monoclonal antibodies followed by fluorescein-labeled goat anti-mouse IgG. After washing, cells were analyzed (5000 per sample) in a FACScan (Becton Dickinson, Mountain View, CA) equipped with 5 W argon laser at 488 nm.

Integrins were immunoprecipitated from cells labeled with 125I as described previously (Rossino et al., 1990; Balzac et al., 1994).

Cell Adhesion and Spreading Assays

Cell adhesion and spreading assays to matrix-coated microtiter plates were performed as described previously (Balzac et al., 1994). To analyze the role of divalent cations in adhesion, cells were plated in "adhesion buffer" [20 mM Tris (pH 7.4), 135 mM NaCl, 5 mM KCl, 2 mM L-glutamine, 1.8 mM glucose, and 1% BSA] containing 1 mM MnCl2, MgCl2, or CaCl2. Where indicated, adhesion was blocked by addition of the beta 1 mAb AIIB2 (1:5 dilution of culture supernatant) or 0.5 mg/ml GRGDSP peptide; the GRGESP peptide was also used as control. Cell adhesion was evaluated by colorimetric assay for acid phosphatase activity as described (Defilippi et al. 1991).

Fibronectin Matrix Assembly Assay

Matrix assembly was evaluated by adding exogenous purified human plasma fibronectin (Engvall and Ruoslahti, 1977) to a final concentration of 200 nM for 2 d to confluent cell monolayers grown on glass coverslips in medium containing 1% serum. Where indicated, inhibitory mAb PB1 against hamster alpha 5beta 1 or mAb H9.2B8 against mouse alpha V was used (10 µg/ml). The resulting fibronectin matrix was then visualized by immunofluorescence.

The same protocol was used to quantitate fibronectin assembly using 100 nM 125I-labeled fibronectin (specific activity, 0.08 mCi/nM). A deoxycholate-insoluble fraction was obtained from cell monolayers as described (McKeown-Longo and Mosher, 1985; Wu et al., 1993, 1995). 125I-labeled fibronectin incorporated into the deoxycholate-insoluble extracellular matrix was analyzed by reducing SDS-PAGE (6% running gel) and autoradiography.

Immunofluorescence Microscopy

For immunofluorescence cells were seeded on circular (1-cm-diameter) glass coverslips in 12-well plates and grown for the indicated time. Where indicated, coverslips were coated with 10 µg/ml human plasma fibronectin. Immunofluorescence staining of paraformaldehyde-fixed cells was performed using a standard protocol (Balzac et al., 1993). A 1:500 dilution of the polyclonal antibody to human fibronectin, a 0.5 µg/ml solution of paxillin mAb, a 1:200 dilution of the alpha V cytoplasmic domain polyclonal antibody, and a 10 µg/ml solution of mAb TS2/16 were used. Bound primary antibodies were then visualized by appropriate rhodamine-labeled secondary antibodies. In some experiments cells were double stained with fluorescein-conjugated phalloidin.

Measurement of Cellular Contractility

Silicone rubber substrata for assessing cellular contractility were made as described previously (Harris et al., 1980; Danowski, 1989). Films were produced by glow discharge polymerization (5 sec, 20 mA). Briefly, 0.5 ml of silicone rubber (dimethyl polysiloxane; viscosity, 10,000-60,000 centistokes; Sigma) was aliquoted into tissue culture dishes and allowed to spread for 24 h. The top of the silicone was then coated with a thin layer of gold-palladium using a cold sputter coater. The UV glow discharge that occurred during the gold-palladium coating polymerized the silicone rubber. Cells were plated for 1 day on the cross-linked rubber substrata in growth medium with 10% serum, and the presence or absence of wrinkles was examined using an inverted phase-contrast Leitz microscope.

Detection of Phosphotyrosine-containing Proteins

To specifically trigger tyrosine phosphorylation of intracellular proteins mediated by the transfected or endogenous integrins, cells were plated on plastic dishes coated with specific monoclonal antibodies as described (Balzac et al., 1994). Cells were lysed in the presence of phosphatase inhibitors, and FAK was immunoprecipitated as described (Retta et al., 1996). After SDS-PAGE, proteins were transferred to nitrocellulose and processed for Western blotting with the anti-phosphotyrosine mAb PY20 followed by peroxidase-conjugated anti-mouse IgG (Sigma). Bound antibodies were visualized by an ECL detection method (Amersham, Buckinghamshire, UK). After stripping with 2% SDS at 42°C for 1 h to remove bound antibodies, the filter was reprobed with the mAb FAK9.2 to visualize the level of FAK protein.

Coimmunoprecipitation of Proteins Interacting with the beta 1 Cytoplasmic Domain

Transfected CHO cells from confluent culture dishes were suspended by EDTA treatment and incubated with 10 µg of purified TS2/16 mAb to human beta 1 for 30 min at 4°C on a rotator. Cells were centrifuged (1000 rpm, 3 min), and the pellets were extracted for 3 min on ice with 50 mM PIPES buffer (pH 6.9) containing 0.5% digitonin, 1 mM MgCl2, 1 mM EGTA, 10 µg/ml leupeptin, 10 µg/ml pepstatin, and 0.5 mM PMSF. Cell extracts were centrifuged (12,000 rpm, 30 min, 4°C), and the resulting supernatants were incubated at 4°C for 45 min with protein G-Sepharose beads. Immunoprecipitates were washed in the same buffer, boiled in SDS sample buffer, and separated by 8% SDS-PAGE. Proteins were transferred onto Immobilon membranes and processed for Western blotting with 8d4 mAb against talin, 1682 mAb against alpha -actinin, or FAK9.2 mAb against FAK.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Preparation of beta 1-Integrin Cytoplasmic Domain Variants and Expression in CHO and beta 1-Null Cells

The cytoplasmic domain of beta 1-integrin consists of a membrane proximal subdomain, shared by all four beta 1 isoforms (common subdomain), and a distal subdomain toward the C terminus, unique for each isoform (variable subdomain) (Figure 1). To investigate the specific role of these two beta 1 cytoplasmic subdomains, we have generated the following mutants (Figure 1): beta 1TR, lacking the entire cytoplasmic domain; beta 1COM, containing only the common subdomain; and beta 1Delta COM-B and beta 1Delta COM-A, in which the common subdomain has been deleted and the variable B and A subdomains are directly linked to the transmembrane segment. These constructs and the natural beta 1B and beta 1A isoforms were expressed in CHO cells (Figure 2A) and in the mouse GD25 fibroblastic cell line, which lacks endogenous beta 1 as a consequence of gene inactivation (Fässler et al., 1995; Wennerberg et al., 1996) (Figure 2, B and C). Previous results showed that human beta 1A and beta 1B isoforms correctly associated with endogenous alpha  subunits in CHO cells (Balzac et al., 1993, 1994). Identical results were obtained with the four beta 1 mutants described above (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results). The major integrin complexes at the GD25 cell surface are alpha 6beta 4-, alpha Vbeta 3-, and alpha Vbeta 5-integrins (Figure 2C; Wennerberg et al., 1996). Transfection of these cells with the above beta 1 constructs led to surface expression of beta 1 integrin heterodimers with the endogenous alpha 3, alpha 5, and alpha 6 subunits but not with the alpha V subunit (Figure 2C). A significant amount of alpha 5 was detected at the surface of untransfected GD25 cells, suggesting that a fraction of the molecule can still reach the cell surface in the absence of the beta  subunit.


View larger version (30K):
[in this window]
[in a new window]
 
Figure 1.   Schematic representation of beta 1A, beta 1B, and cytoplasmic domain deletion mutants prepared for these studies. The amino acid sequences of beta 1A and beta 1B cytoplasmic domain are indicated. The beta 1COM mutant was truncated at threonine 782 and contains only the subdomain common to the different human beta 1 isoforms; the beta 1TR mutant was truncated at isoleucine residue 762 and lacks the entire cytoplasmic domain; the beta 1Delta COM-A and beta 1Delta COM-B lack the common subdomain, so that the distal A and B subdomains, respectively, are directly linked to the transmembrane segment. These mutants were prepared by oligonucleotide-mediated and recombinant PCR mutagenesis as described in MATERIALS AND METHODS.


View larger version (78K):
[in this window]
[in a new window]
 
Figure 2.   Surface expression of transfected beta 1 variants in CHO and GD25 cells. CHO and GD25 cells were transfected with DNA constructs for human beta 1B or beta 1A or for the beta 1 cytoplasmic domain deletion mutants indicated, and positive cells were sorted by panning on beta 1 antibodies as described in MATERIALS AND METHODS. (A and B) To detect surface expression of transfected beta 1 variants, CHO (A) and GD25 (B) transfectants were stained with mAb TS2/16 to human beta 1, followed by fluorescein-labeled anti-mouse IgG, and analyzed by FACS. The level of beta 1 surface expression reported as fluorescence intensity is shown. Untransfected cells were included as a negative control. (C) Integrin heterodimers in 125I-surface-labeled GD25, GD25-beta 1B, and GD25-beta 1A cells as detected by nonreducing SDS-PAGE and autoradiography of immunoprecipitated integrins with antibodies specific for beta 1, alpha 3, alpha 5, alpha 6, and alpha V subunits.

Adhesive Properties of beta 1-Integrin Cytoplasmic Variants

The functional properties of GD25 and CHO cells transfected with either the beta 1B or beta 1A isoform or the four beta 1 cytoplasmic domain mutants were evaluated by testing their adhesive properties toward fibronectin and laminin-1. A previous report showed that GD25 beta 1-null cells adhere to fibronectin via alpha Vbeta 3 integrin (Wennerberg et al., 1996). Here we show that GD25-beta 1B cells have reduced ability to spread on fibronectin and retain a stellate shape with numerous cytoplasmic protrusions (Figure 3A, b). Both untransfected GD25 and GD25-beta 1A cells, on the other hand, showed normal spreading capacity (Figure 3A, a and c). Differences in spreading capacity between GD25-beta 1B and GD25 cells were maximal 1 h after plating on fibronectin in serum-free medium.


View larger version (76K):
[in this window]
[in a new window]
 
Figure 3.   Adhesion and spreading of beta 1 variant-transfected GD25 cells on fibronectin and laminin-1. Dishes were coated with either fibronectin or laminin-1, and cells were plated in serum-free medium for 1 h at 37°C. (A) The morphology of cells adherent to fibronectin (10 µg/ml coating) is shown for GD25 (a), GD25-beta 1B (b), GD25-beta 1A (c), GD25-beta 1TR (d), and GD25-beta 1COM (e). (B) The morphology of the cells plated on laminin-1 (10 µg/ml coating) in the absence (a-c) and presence of 1 mM Mn++ (d-f) is shown for GD25 (a and d), GD25-beta 1B (b and e), and GD25-beta 1A (c and f). Similar results were obtained using increasing doses of laminin-1 up to 50 µg/ml. Note the severe reduction of spreading in GD25-beta 1B cells both on fibronectin and laminin-1. Bars, 25 µm. (C) The histograms show attachment of cells to 10 µg/ml of laminin-1 in the absence (open bars), in the presence of 1 mM Mn++ (slashed bars), and in the presence of 1 mM Mn++ plus the beta 1 blocking mAb AIIB2 (striped bars). Results are plotted ± SE as percentage of input cells and are the mean of three experiments. (D) The graph shows cell attachment to increasing doses of fibronectin both in the absence (closed symbols) and in the presence of 500 µg/ml of GRGDSP peptide (open symbols). Adhesion is expressed as percentage of an equal number of input cells. Symbols used are as follows: GD25 (black-triangle and triangle ), GD25-beta 1B (black-square and square ), and GD25-beta 1A (bullet  and open circle ).

This result in GD25 cells extends previous data obtained in CHO cells (Balzac et al., 1994) and indicates that beta 1B is capable of a trans-dominant negative effect toward alpha Vbeta 3 integrin. Interestingly, neither beta 1TR nor beta 1COM caused reduced spreading when expressed both in GD25 (Figure 3A, d and e) and CHO cells (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results). Moreover, also the beta 1Delta COM-A and beta 1Delta COM-B mutants did not interfere with cell spreading (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results).

We then tested adhesion to laminin-1. GD25 cells do not adhere to laminin-1, allowing the direct evaluation of adhesive properties of beta 1 cytoplasmic domain variants in the absence of functional endogenous integrins. Although expression of beta 1A restored the ability of GD25 cells to adhere and spread on laminin-1, expression of the beta 1B isoforms did not (Figure 3B, a-c), indicating that alpha /beta 1B heterodimers do not bind efficiently to laminin-1. Lack of adhesion to laminin-1 was also observed in beta 1TR- and beta 1COM-transfected GD25 cells (Figure 3C).

To assay whether the adhesive capacity of GD25-beta 1B cells can be modified, we tested Mn++ ions, which are known to increase binding affinity of integrins for their ligands (Gailit and Ruoslahti, 1988). Plating in the presence of 1 mM Mn++ restored adhesive capacity to laminin-1 of GD25-beta 1B (Figure 3, B, b and e, and C) but not of GD25-beta 1TR and GD25-beta 1COM cells (Figure 3C), thus indicating that the beta 1B isoform has unique functional properties with respect to the artificial mutants. Blocking antibodies to human beta 1 (mAb AIIB2) prevented Mn++-dependent adhesion in GD25-beta 1B cells, indicating that Mn++ induces beta 1B to bind its ligand (Figure 3C). Mg++ and Ca++ were also tested and found to be ineffective in inducing cell adhesion to laminin-1 (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results). Interestingly, adhesion of GD25-beta 1B cells to laminin-1 resulted in poor spreading with respect to GD25-beta 1A cells (Figure 3B, e and f).

To test whether lack of adhesion of beta 1B-transfected cells was restricted to laminin-1, we examined the attachment of these cells to fibronectin-coated dishes. Previous results showed that expression of beta 1A in GD25 cells leads to altered susceptibility to the Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) peptide (Wennerberg et al., 1996). In agreement with this, although adhesion of GD25 cells to fibronectin was completely inhibited by 500 µg/ml GRGDSP peptide, only 50% inhibition was observed in GD25-beta 1A cells (Figure 3D), indicating that transfected beta 1A modifies adhesive properties of GD25 cells to fibronectin. On the other hand 500 µg/ml GRGDSP peptide fully inhibited adhesion of GD25-beta 1B on fibronectin, as in the case of GD25 cells (Figure 3D), indicating that the beta 1B molecule does not significantly contribute to cell adhesion to fibronectin.

Cytoplasmic Domain Sequences Affect beta 1-Integrin Ectodomain Conformation

The data discussed above suggest that integrin heterodimers containing the beta 1B subunit are expressed at the cell surface in a conformation that does not allow efficient binding to matrix ligands. To investigate this possibility further, we used two antibodies, mAb 12G10 and mAb 9EG7, which recognize epitopes expressed only in the ligand-competent and ligand-occupied beta 1 (Lenter et al., 1993; Mould et al., 1995). Expression of these epitopes reflects changes in integrin ectodomain conformation, which can also be induced by exposing beta 1 to Mn++ (Bazzoni et al., 1995; Mould et al., 1995). The binding of both 12G10 and 9EG7 mAbs to the beta 1 extracellular domain was always compared with that obtained with mAb 13, which recognizes a constitutive epitope in human beta 1. When cells were probed with mAb 12G10, virtually no binding was detected on GD25-beta 1B and GD25-beta 1COM cells, unless Mn++ was present in the medium (Figure 4, A and B). On the contrary, a high level of mAb 12G10 binding was detected on GD25-beta 1A and GD25-beta 1TR cells, addition of Mn++ causing a further increase (Figure 4, A and B). By comparing the binding values of mAb 12G10 with those of mAb 13, we estimated that only 5-8% of the beta 1B at the cell surface expressed the 12G10 mAb epitope compared with 25-30% for beta 1A. Similar results were obtained with mAb 9EG7 (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results).


View larger version (39K):
[in this window]
[in a new window]
 
Figure 4.   Effect of Mn++ on the conformation of beta 1B, beta 1A, and the four mutants as detected by 12G10 mAb. (A) GD25-beta 1B (left) and GD25-beta 1A (right) cells were analyzed by flow cytometry for surface expression of the 12G10 mAb epitope in the presence or absence of 1 mM Mn++. As a control, cells were also stained with mAb 13, which recognizes an Mn++-insensitive beta 1 epitope. GD25 cells were used as a negative control. (B and C) The histograms show the level of expression of the 12G10 mAb epitope in beta 1-transfected GD25 (B) and CHO (C) cells in the absence (open bars) or presence (striped bars) of 1 mM Mn++. Mean fluorescence intensities are expressed ± SE as percentage of mAb 13 values and represent the mean of five experiments.

Expression of the above beta 1 variants in CHO cells confirmed the data obtained with GD25 transfectans (Figure 4C). Moreover, in the CHO system we also found that beta 1Delta COM-B and beta 1Delta COM-A variants, like beta 1B and beta 1COM, do not express the mAb 12G10 epitope unless exposed to Mn++ ions (Figure 4C).

These data show that all of the beta 1 variants analyzed changed the ectodomain conformation after exposure to Mn++ ions. Despite this, after Mn++ activation only beta 1B, but none of the artificial beta 1 mutants, was able to support cell adhesion, thus indicating that both the ectodomain conformation and specific cytoplasmic subdomains are required for adhesive function. The adhesive function of Mn++-activated beta 1B, however, is not comparable to that of beta 1A, because GD25-beta 1B cells cannot reach full spreading (see Figure 3B, e).

beta 1B Inhibits Fibronectin Matrix Assembly

The assembly of fibronectin matrix in control and transfected cells was evaluated by immunofluorescence staining of cell monolayers incubated with purified human plasma fibronectin as described in MATERIALS AND METHODS.

GD25 untransfected cells assemble thin fibronectin fibrils on the cell apical surface (Figure 5). This process was inhibited by an alpha V-blocking antibody (Figure 5, A, a and b, and B), indicating that alpha Vbeta 3/5 integrins mediate matrix assembly in these cells as suggested previously (Wennerberg et al., 1996). Expression of beta 1B in GD25 cells resulted in dramatic inhibition of fibronectin matrix assembly (Figure 5A, c), thus indicating that beta 1B interferes with alpha V-containing endogenous integrins. Quantitative data, obtained by measuring 125I-labeled fibronectin incorporation in a detergent-insoluble matrix (Figure 5B), indicated a fivefold reduction in matrix assembly in GD25-beta 1B compared with parental cells. Interestingly, the expression of the two mutants beta 1COM (Figure 5A, e and f) and beta 1TR (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results) differed from beta 1B and did not interfere with matrix assembly. Moreover, expression of beta 1A in GD25 cells resulted in increased assembly of fibronectin matrix compared with untransfected cells (Figure 5A, g and h).


View larger version (108K):
[in this window]
[in a new window]
 
Figure 5.   Exogenous fibronectin matrix assembly in control and transfected GD25 cells in the presence of an anti-alpha V-blocking antibody. (A) Confluent cell monolayers were cultured for 2 d with 200 nM human plasma fibronectin either in the absence (a, c, e, and g) or in the presence (b, d, f, and h) of the inhibitory mAb H9.2B8 against mouse alpha V, used to block the endogenous alpha V integrins. Cells were then fixed for 10 min in 3.7% (v/v) paraformaldehyde in PBS, and the fibronectin in the matrix was stained by a polyclonal antibody followed by a rhodamine-labeled anti-rabbit IgG. Bar, 50 µm. (B) Biochemical evaluation of fibronectin matrix assembly. 125I-labeled fibronectin incorporated into deoxycholate-insoluble matrix of cells either in the absence (-) or in the presence (+) of the alpha V-blocking H9.2B8 mAb was visualized by SDS-PAGE and autoradiography. The molecular weight of reduced fibronectin is shown.

To further analyze the beta 1B dominant negative effect, we assayed the fibronectin matrix assembly ability of CHO cells expressing the beta 1B or beta 1A isoform as well as the four beta 1 mutants. As shown in Figure 6, also in CHO cells the expression of beta 1B resulted in a dominant negative effect; moreover, none of the other beta 1 constructs showed this ability. Exogenous fibronectin assembly in these cells is driven by the a5beta 1-integrin, because this function was blocked by the anti-hamster alpha 5beta 1 mAb PB1 (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results). This result indicates that in CHO cells beta 1B interferes with the endogenous a5beta 1 function.


View larger version (111K):
[in this window]
[in a new window]
 
Figure 6.   Fibronectin matrix assembly in control and transfected CHO cells. Confluent cell monolayers were cultured for 2 d with 200 nM human plasma fibronectin as described in MATERIALS AND METHODS. Cells were then fixed for 10 min in 3.7% (v/v) paraformaldehyde in PBS, and the fibronectin in the matrix was stained by a specific polyclonal antibody followed by a rhodamine-labeled anti-rabbit IgG. Note the dramatic reduction of fibronectin assembly in beta 1B-expressing cells. Bar, 80 µm.

Thus, the ability of beta 1B to block fibronectin matrix assembly in both GD25 and CHO cells indicates that this molecule is able to interfere with different classes of integrins involved in this process.

Expression of beta 1-Integrin Variants Specifically Affects Focal Adhesion and Stress Fiber Organization

Given the fact that beta 1B impaired cell spreading and fibronectin matrix assembly, we also examined its ability to affect focal adhesion organization. As shown in Figure 7a, GD25 cells form alpha V-containing prominent focal adhesions when plated on fibronectin-coated dishes, consistent with the reported ability of alpha Vbeta 3 to support attachment to fibronectin in these cells (Wennerberg et al., 1996). GD25-beta 1B cells plated on fibronectin showed a clear reduction of alpha V-containing focal adhesions when compared with GD25 cells (Figure 7, a and c). On the contrary, GD25-beta 1COM (Figure 7e) and GD25-beta 1TR (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results) cells did not show a reduction in alpha V-containing focal adhesions.


View larger version (154K):
[in this window]
[in a new window]
 
Figure 7.   Localization of alpha V- and beta 1-integrin subunits to focal adhesion in control and transfected GD25 cells. Cells were plated on 10 µg/ml fibronectin-coated glass coverslips for 3 h in complete culture medium. Cells were then fixed for 10 min in 3.7% (v/v) paraformaldehyde in PBS, permeabilized with 0.5% Triton X-100 and 3.7% formaldehyde in PBS for 5 min, and stained for alpha V (A, C, E, G) or beta 1 (B, D, F, H) integrins by specific antibodies followed by rhodamine-labeled secondary antibodies. Note the reduction of alpha V-containing focal adhesion in beta 1B-transfected cells. Bar, 15 mm.

beta 1B, beta 1COM (Figure 7, d and f), and beta 1TR (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results) molecules were uniformly distributed on the cell surface, as shown by immunofluorescence; thus beta 1B displaced alpha V heterodimers without localizing to focal adhesions.

We then tested whether focal adhesion localization of cytoskeletal proteins, such as paxillin, and actin organization were also affected. As shown in Figure 8, beta 1B, but not beta 1A or beta 1COM, was able to reduce the number of paxillin-containing focal adhesions (Figure 8a-g). Similar results were obtained when we analyzed actin stress fibers. In fact, beta 1B-expressing cells showed only residual stress fibers in cell protrusions (Figure 8d), whereas cells expressing the other beta 1 constructs did not show significant changes compared with untransfected cells (Figure 8h). The interference of beta 1B on stress fiber organization was also supported by analysis of cell contractility by plating cells on silicon rubber films (Harris et al., 1980; Danowski, 1989). As shown in Figure 9, GD25 cells are able to pull on the substrate, inducing wrinkles in the silicon film. On the other hand, no wrinkles were observed in dishes seeded with GD25-beta 1B cells. Altogether, these data show a specific dominant negative effect of beta 1B on focal adhesion and stress fiber organization.


View larger version (94K):
[in this window]
[in a new window]
 
Figure 8.   Focal adhesion and stress fiber organization in control and transfected GD25 cells. Cells were plated on 10 µg/ml fibronectin-coated glass coverslips for 3 h in complete culture medium. Cells were then fixed for 10 min in 3.7% (v/v) paraformaldehyde in PBS, permeabilized with 0.5% Triton X-100 and 3.7% formaldehyde in PBS for 5 min, and double stained for paxillin (A, C, E, G) and F-actin (B, D, F, H) as described in MATERIALS AND METHODS. Note the reduction of stress fibers and paxillin-containing focal adhesions in GD25-beta 1B cells. Bar, 10 µm.


View larger version (82K):
[in this window]
[in a new window]
 
Figure 9.   Rubber substrate contractility assay. GD25, GD25-beta 1B, and GD25-beta 1A cells were plated for 1 d on silicone rubber substrata and photographed under phase contrast. Note the incapacity of GD25-beta 1B cells to wrinkle the silicon substrate. Bar, 50 µm.

beta 1B Has a Dominant Negative Effect on FAK Tyrosine Phosphorylation

By plating CHO cells on dishes coated with antibodies specific for the transfected human beta 1-integrin, we have previously shown that beta 1B is unable to trigger FAK tyrosine phosphorylation (Balzac et al., 1994). Given the dominant negative effect of beta 1B on cell adhesive functions, we tested the ability of this molecule to interfere with endogenous integrin signaling. CHO cells expressing different beta 1-integrin cytoplasmic variants were plated on dishes coated with anti-hamster beta 1, antibody and tyrosine phosphorylation of FAK was evaluated by Western blot. As shown in Figure 10, A and B, endogenous hamster beta 1A had a reduced capacity to induce FAK tyrosine phosphorylation in cells expressing beta 1B but not in cells expressing human beta 1A or the four beta 1 cytoplasmic domain mutants (Figure 10C). At the same time, the four beta 1 mutants, like beta 1B, were not capable of triggering FAK tyrosine phosphorylation to a significant extent (Figure 10D).


View larger version (28K):
[in this window]
[in a new window]
 
Figure 10.   Inhibition of beta 1A-induced FAK tyrosine phosphorylation by beta 1B expression. To specifically trigger tyrosine phosphorylation of intracellular proteins mediated by the the endogenous or transfected beta 1 integrins, cells were plated on plastic dishes coated with the anti-hamster beta 1 mAb 7E2 (A-C) or with the anti-human beta 1 mAb TS2/16 (D), respectively. (A and B) Tyrosine phosphorylation of total cellular proteins (A) and FAK (B) induced by endogenous hamster beta 1A was detected by Western blotting with anti-phosphotyrosine mAb PY20. Note reduced tyrosine phosphorylation of 116- to 130-kDa proteins (A) and FAK (B) in beta 1B-transfected CHO cells. (B') The reprobing of the blot with FAK antibodies is shown. (C) The tyrosine phosphorylation of FAK via endogenous beta 1A was also evaluated in CHO cells expressing the different cytoplasmic domain mutants. Cells were plated on poly-L-lysine (lanes 1) for control and on 7E2 mAb to endogenous hamster beta 1 (lanes 2). (C') The reprobing of the blot with FAK antibodies is shown. (D) The ability of the different mutants to trigger FAK tyrosine phosphorylation directly was evaluated by plating cells on mAb TS2/16 to the transfected human beta 1 (lanes 2') or poly-L-lysine as control (lanes 1).

Association of Talin and alpha -Actinin with beta 1 Cytoplasmic Domain Variants

To evaluate the ability of different beta 1 cytoplasmic domain variants to interact with talin, alpha -actinin, and FAK, we performed coimmunoprecipitation studies by extracting cells under mild detergent conditions (see MATERIALS AND METHODS). As detected by Western blots, talin was coprecipitated with beta 1A but not with beta 1B, beta 1COM, or beta 1TR (Figure 11). On the other hand, alpha -actinin was coprecipitated with beta 1A, beta 1B, and beta 1COM but not with beta 1TR (Figure 11). The amount of alpha -actinin associated with beta 1B and beta 1COM immunoprecipitates, however, was reduced compared with beta 1A immunoprecipitate.


View larger version (65K):
[in this window]
[in a new window]
 
Figure 11.   Association of talin and alpha -actinin with beta 1 cytoplasmic domain variants. CHO cells transfected with beta 1B, beta 1A, beta 1COM, and beta 1TR integrin variants were incubated in suspension with TS2/16 mAb to human beta 1, and cells were lysated in digitonin-containing buffer. Immunocomplexes were recovered from cell extracts with protein G-Sepharose beads and analyzed by Western blotting with talin antibody. The blot was stripped and reprobed with alpha -actinin antibody. Arrowheads point to the talin and alpha -actinin bands.

FAK was not detected in the immunocomplexes associated with any of the four beta 1 molecules tested (Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo, and Tarone, unpublished results).

These data show that beta 1B is incapable of interacting with talin but retains the ability to bind alpha -actinin. This property is shared with beta 1COM variants.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

We have previously shown that beta 1B, an integrin isoform with a distinct cytoplasmic domain, causes reduced cell spreading and migration when expressed in CHO cells (Balzac et al., 1994). In the present study we have examined the role of specific beta 1 cytoplasmic subdomains in determining this dominant negative function. To achieve this aim, we have constructed four deletion mutants (see Figure 1): beta 1TR, lacking the entire cytoplasmic domain; beta 1COM, lacking the cytoplasmic distal subdomain; and beta 1Delta COM-B and beta 1Delta COM-A, in which the distal B and A subdomains are linked to the transmembrane segment by deletion of the common region.

These molecules were expressed both in GD25 cells, which lack the endogenous beta 1 as a consequence of gene knockout (Wennerberg et al., 1996), and in CHO cells. Adhesion experiments in GD25 cells showed that beta 1B is unable to support cell adhesion. In fact, GD25-beta 1B cells, like untransfected GD25 cells, do not adhere to laminin-1, despite correct surface expression of alpha 3beta 1B-, alpha 5beta 1B-, and alpha 6beta 1B-integrin heterodimers. Moreover, beta 1B-containing heterodimers are not functional in mediating adhesion to fibronectin. On the other hand, beta 1A supports adhesion of GD25 cells to laminin-1 and fibronectin. beta 1TR and beta 1COM behave as beta 1B, being unable to support cell adhesion to laminin-1.

The inability of beta 1B complexes to mediate cell adhesion can be rescued by treating cells with Mn++ ions, which are known to increase binding affinity of integrins for their ligands (Gailit and Ruoslahti, 1988). Mn++ treatment, however, did not restore the adhesive function of beta 1TR- and beta 1COM-transfected GD25 cells, indicating that the beta 1B cytoplasmic domain confers specific adhesive function.

Mn++ ions affect conformation of the beta 1 ectodomain. This was confirmed by using 12G10 and 9EG7 mAbs, which recognize conformation-specific epitopes in the beta 1 ectodomain. Both mAbs bind very poorly to beta 1B compared with beta 1A. Addition of Mn++ to the medium strongly increases 12G10 and 9EG7 mAb binding to beta 1B. Interestingly, beta 1TR, which does not support adhesion to laminin-1 even in the presence of Mn++ ions, constitutively expresses 12G10 and 9EG7 epitopes, indicating that ectodomain conformation is not sufficient to endow beta 1 with adhesive properties, but cytoplasmic sequences are also required. On the other hand, the beta 1COM variant, similarly to beta 1B, expresses 12G10 and 9EG7 epitopes in response to Mn++, but it does not support cell adhesion. Thus, the conserved common region of the beta 1 cytoplasmic domain, present in the beta 1COM mutant, is not sufficient to support cell adhesion but needs to be linked to either the A or B distal subdomain. Although the combination COM + A gives raise to a fully functional molecule, COM + B is only partially functional, because it requires Mn++ to support attachment and does not allow cell spreading.

The results presented show that beta 1B and the four beta 1 cytoplasmic domain mutants beta 1TR, beta 1COM, beta 1Delta COM-A, and beta 1Delta COM-B are incapable of inducing fibronectin matrix assembly. Interestingly, however, beta 1B shows a strong capacity to inhibit matrix assembly controlled by endogenous integrins, a property that is not shares by beta 1TR, beta 1COM, beta 1Delta COM-A, and beta 1Delta COM-B. Fibronectin matrix assembly involves different receptors in CHO and GD25 beta 1-null cells. Although alpha 5beta 1 is the major CHO integrin receptor involved in this function, in GD25 cells this role is played by alpha V-containing integrin complexes. The ability of beta 1B to inhibit fibronectin matrix assembly in both cell types indicates a dominant negative effect on both alpha 5beta 1 and alpha Vbeta 3/beta 5 integrins. Work in progress indicates that beta 1B also inhibits fibronectin matrix assembly in epithelial cells and primary mouse fibroblasts, thus showing that this is a general property of beta 1B in several cell types.

We also found a strong effect of beta 1B on focal adhesion and actin stress fiber organization. In fact, in GD25 cells that adhere to fibronectin via alpha Vbeta 3, beta 1B expression led to a reduced number of alpha V-containing focal adhesions. In these cells beta 1B is uniformly diffuse at the cell surface but does not associate with the alpha V subunit; thus reduction of alpha V localization to focal adhesion cannot be explained by competitive displacement. On the other hand, paxillin and F-actin staining showed an overall reduction of focal adhesions and stress fibers in GD25-beta 1B cells. This reduction could explain the GD25-beta 1B cells' poor spreading on fibronectin as well as the reduced contractility on silicon rubber film. The interference with actin cytoskeleton organization is specific for the beta 1B isoform, because neither beta 1TR nor beta 1COM leads to this effect.

To investigate at a molecular level the dominant negative effects of beta 1B, we analyzed the signal transduction ability of endogenous